Antibiotic susceptibility pattern of gram-positive cocci cultured from patients in three university hospitals in Tehran, Iran during 2001-2005

Acta Medica Iranica

Volumn 47, Issue 4, 2009, Pages 329-334

  Aligholi, Marzieh ^a   Emaneini, Mohammad ^a   Jabalameli, Fereshteh ^a   Shahsavan, Shadi ^a   Abdolmaleki, Zohreh ^b   Sedaghat, Hossein ^a   Jonaidi, Nematollah ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antimicrobial susceptibility patterns; Gram positive Cocci; MRSA; Pneumococci; VRE

Indexed keywords

CEFTRIAXONE; ERYTHROMYCIN; GENTAMICIN; OXACILLIN; PENICILLIN BINDING PROTEIN 2A; PENICILLIN G; RIFAMPICIN; STREPTOMYCIN; TEICOPLANIN; VANCOMYCIN;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GRAM POSITIVE COCCI; HUMAN; IRAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PENICILLIN RESISTANCE; PRACTICE GUIDELINE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; UNIVERSITY HOSPITAL; VANA GENE; VANB GENE;

EID: 71849105533     PISSN: 00446025     EISSN: 00446025     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Jeljaszewicz J, Mlynarczyk G, Mlynarczyk A. Antibiotic resistance in Gram-positive cocci. Int J Antimicrob Agents 2000; 16(4): 473-478
2. Rice LB. Antimicrobial resistance in gram-positive bacteria. Am J Infect Control 2006; 34(5 Suppl 1): S11-9.
3. A Report from the National Nosocomial Infections Surveillance (NNIS) System. Nosocomial infection rates for interhospital comparison: limitations and possible solutions. Infect Control Hosp Epidemiol 1991; 12(10): 609-621
4. A report from the NNIS System. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1997, issued May 1997. Am J Infect Control 1997; 25(6): 477-487
5. Pezzlo M. Aerobic bacteriology. In: Isenberg HD, editor. Clinical Microbiology Procedures Handbook. Washington, DC: American Society for Microbiology (ASM Press); 1992. p. 1. 19. 20. 47.
6. th ed. Washington, DC: American Society for Microbiology (ASM Press) 1999; p. 64-76.
7. National Committee for Clinical Laboratory Standards (NCCLS). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A4. Wayne, PA: NCCLS; 2004.
8. Sahm DF, Peterson DE, Critchley IA, Thornsberry C. Analysis of ciprofloxacin activity against Streptococcus pneumoniae after 10 years of use in the United States. Antimicrob Agents Chemother 2000; 44(9): 2521-2524 (Pubitemid 30650906)
9. Vannuffel P, Gigi J, Ezzedine H, Vandercam B, Delmee M, Wauters G, et al. Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR. J Clin Microbiol 1995; 33(11): 2864-2867
10. Cuevas O, Cercenado E, Vindel A, Guinea J, Sánchez-Conde M, Sánchez-Somolinos M, et al. Evolution of the antimicrobial resistance of Staphylococcus spp. in Spain: five nationwide prevalence studies, 1986 to 2002. Antimicrob Agents Chemother 2004; 48(11): 4240-4245
11. Madani TA, Al-Abdullah NA, Al-Sanousi AA, Ghabrah TM, Afandi SZ, Bajunid HA. Methicillin-resistant Staphylococcus aureus in two tertiary-care centers in Jeddah, Saudi Arabia. Infect Control Hosp Epidemiol 2001; 22(4): 211-6.
12. El Kholy A, Baseem H, Hall GS, Procop GW, Longworth DL. Antimicrobial resistance in Cairo, Egypt 1999-2000: a survey of five hospitals. J Antimicrob Chemother 2003; 51(3): 625-630
13. Baddour MM, Abuelkheir MM, Fatani AJ. Trends in antibiotic susceptibility patterns and epidemiology of MRSA isolates from several hospitals in Riyadh, Saudi Arabia. Ann Clin Microbiol Antimicrob 2006; 5: 30.
14. Sader HS, Streit JM, Fritsche TR, Jones RN. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004). Clin Microbiol Infect 2006; 12(9): 844-852
15. Arias CA, Reyes J, Zúñiga M, Cortés L, Cruz C, Rico CL, et al. Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002. J Antimicrob Chemother 2003; 51(1): 59-68.
16. Gales AC, Sader HS, Jones RN. Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres. Clin Microbiol Infect 2005; 11(2): 95-100. (Pubitemid 40253813)
17. Muller-Serieys C, Drugeon HB, Etienne J, Lascols C, Leclercq R, Nguyen J, et al. Activity of linezolid against Gram-positive cocci isolated in French hospitals as determined by three in-vitro susceptibility testing methods. Clin Microbiol Infect 2004; 10(3): 242-246 (Pubitemid 38379964)
18. Henwood CJ, Livermore DM, Johnson AP, James D, Warner M, Gardiner A. Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group. J Antimicrob Chemother 2000; 46(6): 931-940 (Pubitemid 32000604)
19. Schouten MA, Voss A, Hoogkamp-Korstanje JA. Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group. Antimicrob Agents Chemother 1999; 43(10): 2542-2546 (Pubitemid 29471244)
20. Guiney M, Urwin G. Frequency and antimicrobial susceptibility of clinical isolates of enterococci. Eur J Clin Microbiol Infect Dis 1993; 12(5): 362-366 (Pubitemid 23184852)
21. Schmitz FJ, Verhoef J, Fluit AC. Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY Antimicrobial Surveillance Programme. Eur J Clin Microbiol Infect Dis 1999; 18(6): 414-421 (Pubitemid 29531206)
22. Udo EE, Al-Sweih N, Phillips OA, Chugh TD. Species prevalence and antibacterial resistance of enterococci isolated in Kuwait hospitals. J Med Microbiol 2003; 52(Pt 2): 163-168 (Pubitemid 36205265)
23. Nelson RR, McGregor KF, Brown AR, Amyes SG, Young H. Isolation and characterization of glycopeptide-resistant enterococci from hospitalized patients over a 30-month period. J Clin Microbiol 2000; 38(6): 2112-2116 (Pubitemid 30414324)
24. Jones ME, Draghi DC, Thornsberry C, Karlowsky JA, Sahm DF, Wenzel RP. Emerging resistance among bacterial pathogens in the intensive care unit: a European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob 2004; 3: 14.
25. Feizabadi MM, Asadi S, Aliahmadi A, Parvin M, Parastan R, Shayegh M, et al. Drug resistant patterns of enterococci recovered from patients in Tehran during 2000-2003. Int J Antimicrob Agents 2004; 24(5): 521-522
26. Fatholahzadeh F, Hashemi FB, Emaneini M, Aligholi M, Nakhjavani FA, and Kazemi B. Detection of Vancomycin Resistant Enterococci (VRE) Isolated From Urinary Tract Infections (UTI) in Tehran, Iran. Daru 2006; 14(3): 141-145 (Pubitemid 44808348)
27. Bonten MJ, Willems R, Weinstein RA. Vancomycinresistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 2001; 1(5): 314-325
28. Huycke MM, Sahm DF, Gilmore MS. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis 1998; 4(2): 239-249
29. Decousser JW, Pina P, Viguier F, Picot F, Courvalin P, Allouch P; ColBVH Study Group. Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002. Antimicrob Agents Chemother 2004; 48(9): 3636-3639
30. European Antimicrobial Resistance Surveillance System. EARSS interactive database access [Online]. 2005 Oct 26. Available from: URL:http://www.earss. rivm.nl/PAGINA/interwebsite/home-earss.html
31. Cars O, Mölstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357(9271): 1851-1853 (Pubitemid 32539121)
32. Pfaller MA, Jones RN, Doern GV, Kugler K. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998; 42(7): 1762-1770